467900login-checkCareDx Innovation Showcased in Record-Breaking Number of Scientific Abstracts with Over 50 Presented at 2022 Transplant Congress |
First Oral Presentation of OKRA Study Data Highlights CareDx Leadership in Multimodality KidneyCare
Symposium Highlights Power of CareDx Artificial Intelligence Solutions
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Jun. 1, 2022– CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced a leading presence at the 2022 American Transplant Congress (ATC) with over 50 oral and scientific poster presentations. CareDx will also be sponsoring a symposium, three product theatres, and an Innovation Day session covering the latest innovations in transplantation.1 The ATC meeting takes place June 4-8 in Boston, Massachusetts. Read the full press release on CareDx.com.
467900login-checkCareDx Innovation Showcased in Record-Breaking Number of Scientific Abstracts with Over 50 Presented at 2022 Transplant Congress |